United States · FDA National Drug Code directory
Cefepime
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-1004_34afba66-733f-4403-83d1-1b67b8a6633b
- Product NDC
- 67184-1004
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- CEFEPIME HYDROCHLORIDE
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160201
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFEPIME HYDROCHLORIDE — 2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (67184-1004-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL · 67184-1004-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →